{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:11:57Z","timestamp":1778904717806,"version":"3.51.4"},"reference-count":35,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.1248\/bpb.b26-00041","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:09:32Z","timestamp":1778623772000},"page":"794-801","source":"Crossref","is-referenced-by-count":0,"title":["Tramadol Eye Drop Reduces Ocular Nocifensive Behavior Not Primarily Mediated by &lt;i&gt;\u03bc&lt;\/i&gt;-Opioid Receptor Activation in a Rat Dry Eye Model"],"prefix":"10.1248","volume":"49","author":[{"given":"Shogo","family":"Nagaoka","sequence":"first","affiliation":[{"name":"Rohto Pharmaceutical Co., Ltd., 6\u20135\u20134 Kunimidai, Kizugawa, Kyoto 619\u20130216, Japan"},{"name":"Department of Pharmacology, School of Medicine, Kanazawa Medical University, 1\u20131 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 920\u20130293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Takai","sequence":"additional","affiliation":[{"name":"Rohto Pharmaceutical Co., Ltd., 6\u20135\u20134 Kunimidai, Kizugawa, Kyoto 619\u20130216, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kiyoi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Kanazawa Medical University, 1\u20131 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 920\u20130293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Masuoka","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Kanazawa Medical University, 1\u20131 Daigaku, Uchinada-machi, Kahoku-gun, Ishikawa 920\u20130293, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F. TFOS DEWS II Definition and Classification report. <i>Ocul. Surf.<\/i>, <b>15<\/b>, 276\u2013283 (2017).","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Guo LW, Akpek E. The negative effects of dry eye disease on quality of life and visual function. <i>Turk. J. Med. Sci.<\/i>, <b>50<\/b> (SI-2), 1611\u20131615 (2020).","DOI":"10.3906\/sag-2002-143"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sayegh RR, Yu Y, Farrar JT, Kuklinski EJ, Shtein RM, Asbell PA, Maguire MG. Ocular discomfort and quality of life among patients in the dry eye assessment and management study. <i>Cornea<\/i>, <b>40<\/b>, 869\u2013876 (2021).","DOI":"10.1097\/ICO.0000000000002580"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Belmonte C, Nichols JJ, Cox SM, Brock JA, Begley CG, Bereiter DA, Dartt DA, Galor A, Hamrah P, Ivanusic JJ, Jacobs DS, McNamara NA, Rosenblatt MI, Stapleton F, Wolffsohn JS. TFOS DEWS II pain and sensation report. <i>Ocul. Surf.<\/i>, <b>15<\/b>, 404\u2013437 (2017).","DOI":"10.1016\/j.jtos.2017.05.002"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Galor A, Levitt RC, Felix ER, Martin ER, Sarantopoulos CD. Neuropathic ocular pain: an important yet underevaluated feature of dry eye. <i>Eye<\/i>, <b>29<\/b>, 301\u2013312 (2015).","DOI":"10.1038\/eye.2014.263"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Galor A, Moein HR, Lee C, Rodriguez A, Felix ER, Sarantopoulos KD, Levitt RC. Neuropathic pain and dry eye. <i>Ocul. Surf.<\/i>, <b>16<\/b>, 31\u201344 (2018).","DOI":"10.1016\/j.jtos.2017.10.001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Vehof J, Kozareva D, Hysi PG, Harris J, Nessa A, Williams FK, Bennett DL, McMahon SB, Fahy SJ, Direk K, Spector TD, Hammond CJ. Relationship between dry eye symptoms and pain sensitivity. <i>JAMA Ophthalmol.<\/i>, <b>131<\/b>, 1304\u20131308 (2013).","DOI":"10.1001\/jamaophthalmol.2013.4399"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Nortey J, Smith D, Seitzman GD, Gonzales JA. Topical Therapeutic options in corneal neuropathic pain. <i>Front. Pharmacol.<\/i>, <b>12<\/b>, 769909 (2022).","DOI":"10.3389\/fphar.2021.769909"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in tramadol: pharmacology, metabolism, and misuse. <i>Anesth. Analg.<\/i>, <b>124<\/b>, 44\u201351 (2017).","DOI":"10.1213\/ANE.0000000000001683"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miyano K, Minami K, Yokoyama T, Ohbuchi K, Yamaguchi T, Murakami S, Shiraishi S, Yamamoto M, Matoba M, Uezono Y. Tramadol and its metabolite m1 selectively suppress transient receptor potential ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity. <i>Anesth. Analg.<\/i>, <b>120<\/b>, 790\u2013798 (2015).","DOI":"10.1213\/ANE.0000000000000625"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Marincs\u00e1k R, T\u00f3th BI, Czifra G, Szab\u00f3 T, Kov\u00e1cs L, B\u00edr\u00f3 T. The analgesic drug, tramadol, acts as an agonist of the transient receptor potential vanilloid-1. <i>Anesth. Analg.<\/i>, <b>106<\/b>, 1890\u20131896 (2008).","DOI":"10.1213\/ane.0b013e318172fefc"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zagon IS, Klocek MS, Sassani JW, McLaughlin PJ. Dry eye reversal and corneal sensation restoration with topical naltrexone in diabetes mellitus. <i>Arch. Ophthalmol.<\/i>, <b>127<\/b>, 1468\u20131473 (2009).","DOI":"10.1001\/archophthalmol.2009.270"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zagon IS, Campbell AM, Sassani JW, McLaughlin PJ. Spontaneous episodic decreased tear secretion in rats is related to opioidergic signaling pathways. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>53<\/b>, 3234\u20133240 (2012).","DOI":"10.1167\/iovs.11-9051"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kiyoi T, Nakajima A, He Q, Liu L, Zheng S, Kobayashi S, Uwada J, Masuoka T. Tear deficiency transforms spatial distribution of corneal calcitonin gene-related peptide-positive nerves in rats. <i>Front. Cell. Neurosci.<\/i>, <b>19<\/b>, 1619310 (2025).","DOI":"10.3389\/fncel.2025.1619310"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Masuoka T, Yamashita Y, Nakano K, Takechi K, Niimura T, Tawa M, He Q, Ishizawa K, Ishibashi T. Chronic tear deficiency sensitizes transient receptor potential vanilloid 1-mediated responses in corneal sensory nerves. <i>Front. Cell. Neurosci.<\/i>, <b>14<\/b>, 598678 (2020).","DOI":"10.3389\/fncel.2020.598678"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Masuoka T, Yamashita Y, Yoshida J, Nakano K, Tawa M, Nishio M, Ishibashi T. Sensitization of glutamate receptor-mediated pain behaviour <i>via<\/i> nerve growth factor-dependent phosphorylation of transient receptor potential V1 under inflammatory conditions. <i>Br. J. Pharmacol.<\/i>, <b>177<\/b>, 4223\u20134241 (2020).","DOI":"10.1111\/bph.15176"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Bereiter DA, Rahman M, Thompson R, Stephenson P, Saito H. TRPV1 and TRPM8 channels and nocifensive behavior in a rat model for dry eye. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>59<\/b>, 3739\u20133746 (2018).","DOI":"10.1167\/iovs.18-24304"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Meng ID, Barton ST, Mecum NE, Kurose M. Corneal sensitivity following lacrimal gland excision in the rat. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>56<\/b>, 3347\u20133354 (2015).","DOI":"10.1167\/iovs.15-16717"},{"key":"19","unstructured":"19) Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K. Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>42<\/b>, 96\u2013100 (2001)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Xiao F, Cui H, Zhong X. Beneficial effect of daidzin in dry eye rat model through the suppression of inflammation and oxidative stress in the cornea. <i>Saudi J. Biol. Sci.<\/i>, <b>25<\/b>, 832\u2013837 (2018).","DOI":"10.1016\/j.sjbs.2016.11.016"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. <i>Ocul. Surf.<\/i>, <b>17<\/b>, 55\u201359 (2019).","DOI":"10.1016\/j.jtos.2018.08.004"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Carstens E, Kuenzler N, Handwerker HO. Activation of neurons in rat trigeminal subnucleus caudalis by different irritant chemicals applied to oral or ocular mucosa. <i>J. Neurophysiol.<\/i>, <b>80<\/b>, 465\u2013492 (1998).","DOI":"10.1152\/jn.1998.80.2.465"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Joubert F, Guerrero-Moreno A, Fakih D, Reboussin E, Gaveriaux-Ruff C, Acosta MC, Gallar J, Sahel JA, Bodineau L, Baudouin C, Rost\u00e8ne W, M\u00e9lik-Parsadaniantz S, R\u00e9aux-Le Goazigo A. Topical treatment with a mu opioid receptor agonist alleviates corneal allodynia and corneal nerve sensitization in mice. <i>Biomed. Pharmacother.<\/i>, <b>132<\/b>, 110794 (2020).","DOI":"10.1016\/j.biopha.2020.110794"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Garc\u00eda-L\u00f3pez C, G\u00f3mez-Huertas C, S\u00e1nchez-Gonz\u00e1lez JM, Borroni D, Rodr\u00edguez-Calvo-de-Mora M, Romano V, Rachwani-Anil R, Ramos-L\u00f3pez JF, Ortiz-P\u00e9rez S, Rocha-de-Lossada C. Opioids and ocular surface pathology: a literature review of new treatments horizons. <i>J. Clin. Med.<\/i>, <b>11<\/b>, 1424 (2022).","DOI":"10.3390\/jcm11051424"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Peyman GA, Rahimy MH, Fernandes ML. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. <i>Br. J. Ophthalmol.<\/i>, <b>78<\/b>, 138\u2013141 (1994).","DOI":"10.1136\/bjo.78.2.138"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Wenk NH, Nannenga NM, Honda NC. Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea. <i>Pain<\/i>, <b>105<\/b>, 455\u2013465 (2003).","DOI":"10.1016\/S0304-3959(03)00260-4"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Belmonte C, Acosta MC, Merayo-Lloves J, Gallar J. What causes eye pain? <i>Curr. Ophthalmol. Rep.<\/i>, <b>3<\/b>, 111\u2013121 (2015).","DOI":"10.1007\/s40135-015-0073-9"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Szallasi A, Blumberg PM. Complex Regulation of TRPV1 by Vanilloids. <i>TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades<\/i>. (Liedtke WB, Heller S eds.) Chapter 6, CRC Press\/Taylor &amp; Francis, Boca Raton, FL, pp. 85\u2013104 (2007).","DOI":"10.1201\/9781420005844.ch6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Zhai K, Liskova A, Kubatka P, Busselberg D. Calcium entry through TRPV1: a potential target for the regulation of proliferation and apoptosis in cancerous and healthy cells. <i>Int. J. Mol. Sci.<\/i>, <b>21<\/b>, 4177 (2020).","DOI":"10.3390\/ijms21114177"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Senning EN, Gordon SE. Activity and Ca<sup>2+<\/sup> regulate the mobility of TRPV1 channels in the plasma membrane of sensory neurons. <i>eLife<\/i>, <b>4<\/b>, e03819 (2015).","DOI":"10.7554\/eLife.03819"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. <i>Dtsch. Arztebl. Int.<\/i>, <b>112<\/b>, 71\u201382 (2015).","DOI":"10.3238\/arztebl.2015.0071"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) O\u2019Neil EC, Henderson M, Massaro-Giordano M, Bunya VY. Advances in dry eye disease treatment. <i>Curr. Opin. Ophthalmol.<\/i>, <b>30<\/b>, 166\u2013178 (2019).","DOI":"10.1097\/ICU.0000000000000569"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Simsek C, Kojima T, Nakamura S, Dogru M, Tsubota K. The Effects of rebamipide 2% ophthalmic solution application on murine subbasal corneal nerves after environmental dry eye stress. <i>Int. J. Mol. Sci.<\/i>, <b>20<\/b>, 4031 (2019).","DOI":"10.3390\/ijms20164031"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Lasagni Vitar RM, Barbariga M, Fonteyne P, Bignami F, Rama P, Ferrari G. Modulating ocular surface pain through neurokinin-1 receptor blockade. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>62<\/b>, 26 (2021).","DOI":"10.1167\/iovs.62.3.26"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Cuvas Apan O, Ozer MA, Takir S, Apan A, Sengul D. Effect of topical administration of tramadol on corneal wound healing in rats. <i>Int. Ophthalmol.<\/i>, <b>36<\/b>, 675\u2013680 (2016).","DOI":"10.1007\/s10792-016-0184-9"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00041\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:19Z","timestamp":1778901979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b26-00041\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b26-00041","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"b26-00041"}}